Because GSK360A chemically activates the HIF system by its inhibition of PHD, we hypothesized that its administration prior to cerebral ischemia surgery would provide a significant and beneficial brain protective strategy for use prior to surgery. This evidence concerns the gene PDC and Cerebral ischemia.